Get started
Author

Silvia Díaz-Fernández

Observed names: S. Diaz-Fernandez, S. Díaz-Fernández, Silvia Diaz-Fernandez, Silvia Díaz Fernández, Sylvia Díaz-Fernández
ORCID: 0000-0002-6537-8296
Observed ORCID: 0000-0002-6537-8296
OpenAlex ID: A5102732066
Suicide attempts in people with schizophrenia before and after participating in an intensive case managed community program: A 20-year follow-up
2019 · Sylvia Díaz-Fernández, Danny F Frías-Ortiz, et al. · Psychiatry Research · 33
Paliperidone Palmitate Every Three Months (PP3M) 2-Year Treatment Compliance, Effectiveness and Satisfaction Compared with Paliperidone Palmitate-Monthly (PP1M) in People with Severe Schizophrenia
2021 · Juan J. Fernández-Miranda, Silvia Díaz-Fernández, et al. · Journal of Clinical Medicine · 30
PDF
Gender and addiction and other mental disorders comorbidity: sociodemographic, clinical, and treatment differences
2023 · Silvia Díaz Fernández, Juan José Fernandez Miranda, et al. · Archives of Women s Mental Health · 23
PDF
Tolerability of effective high doses of paliperidone palmitate in patients with severe resistant schizophrenia
2016 · Juan J. Fernández-Miranda, Silvia Díaz-Fernández · International Clinical Psychopharmacology · 23
Oral Versus Long-Acting Injectable Antipsychotic Treatment for People With Severe Schizophrenia: A 5-Year Follow-up of Effectiveness
2021 · Juan J. Fernández-Miranda, Silvia Díaz-Fernández, et al. · The Journal of Nervous and Mental Disease · 14
Effectiveness of More Personalized, Case-Managed, and Multicomponent Treatment for Patients with Severe Schizophrenia Compared to the Standard Treatment: A Ten-Year Follow-Up
2022 · Juan J. Fernández-Miranda, Silvia Díaz-Fernández, et al. · Journal of Personalized Medicine · 13
PDF
Mirror image study (10 years of follow-up and 10 of standard pre-treatment) of psychiatric hospitalizations of patients with severe schizophrenia treated in a community-based, case-managed programme
2022 · Silvia Díaz-Fernández, Danny Francisco Frías-Ortiz, et al. · Revista de Psiquiatría y Salud Mental (English Edition) · 13
Concurrencia de trastorno por consumo de sustancias y de otro trastorno mental en personas en tratamiento por alguno de ellos en España
2021 · Juan José Fernández-Miranda, Julio Fontoba-Díaz, et al. · Adicciones · 13
PDF
The Use of Second-Generation Antipsychotics in Patients with Severe Schizophrenia in the Real World: The Role of the Route of Administration and Dosage—A 5-Year Follow-Up
2022 · Juan J. Fernández-Miranda, Silvia Díaz-Fernández, et al. · Biomedicines · 10
PDF
Differences in Substance Use Disorders and Other Mental Disorders in Mental Health and Addiction Settings: Sociodemographic, Clinical, Drug Treatment, and Gender Differences
2022 · Juan José Fernández-Miranda, Francisco Pascual-Pastor, et al. · International Journal of Mental Health and Addiction · 8
PDF
Estudio en imagen en espejo (10 años de seguimiento y 10 de pretratamiento estándar) de ingresos hospitalarios de personas con esquizofrenia grave en un programa comunitario con gestión de casos
2019 · Silvia Díaz-Fernández, Danny Francisco Frías-Ortiz, et al. · Revista de Psiquiatría y Salud Mental · 8
The mental health nurse as case manager of a patient with severe schizophrenia
2022 · Silvia Díaz-Fernández · Enfermería Clínica (English Edition) · 6
La enfermera especialista en salud mental en la gestión del caso de una paciente con esquizofrenia grave
2021 · Silvia Díaz-Fernández · Enfermería Clínica · 5
Long-Acting Injectable Second-Generation Antipsychotics in Seriously Ill Patients with Schizophrenia: Doses, Plasma Levels, and Treatment Outcomes
2024 · Juan José Fernández-Miranda, Silvia Díaz-Fernández, et al. · Biomedicines · 3
PDF
Plasmatic Levels and Response to Variable Doses of Monthly Aripiprazole and Three-Month Paliperidone in Patients with Severe Schizophrenia. Treatment Adherence, Effectiveness, Tolerability, and Safety
2023 · Juan J Fernández-Miranda, Silvia Díaz-Fernández · Neuropsychiatric Disease and Treatment · 2
PDF
Adherence, Tolerability and Effective Doses of Aripiprazole Once-monthly in the Long-term Treatment of Patients with Severe Schizophrenia
2021 · Juan J. Fernández-Miranda, Silvia Díaz-Fernández, et al. · Current Pharmaceutical Design · 2
Treatment adherence and hospitalizations of patients with severe schizophrenia treated in an integrated, community based, case managed program vs. standard care.
2021 · Silvia Diaz-Fernandez · International Journal of Integrated Care · 1
PDF
Cognitive performance in patients with major depressive disorder treated with vortioxetine compared with escitalopram and venlafaxine
2017 · J.J. Fernandez-Miranda, D.F. Frias-Ortiz, et al. · European Neuropsychopharmacology · 1
P.3.d.010 Effectiveness, tolerability and treatment adherence of high doses of paliperidone palmitate in patients with severe schizophrenia
2015 · J.J. Fernandez-Miranda, S. Diaz-Fernandez · European Neuropsychopharmacology · 1
Use of high doses of second-generation long-acting antipsychotics in patients with resistant schizophrenia. Treatment compliance, effectiveness, and tolerability
2026 · J.J. Fernandez-Miranda, S. Díaz-Fernández · Neuroscience Applied
Paliperidone Palmitate every three months (PP3M) compared to PP1M in people with severe schizophrenia. Treatment outcomes and satisfaction
2026 · J.J. Fernandez-Miranda, S. Díaz-Fernández · Neuroscience Applied
Effectiveness of a community-based, multicomponent and case managed treatment for patients with severe schizophrenia
2025 · J. J. Fernández-Miranda, S. Díaz-Fernández, et al. · European Psychiatry
PDF
Use of high doses of second-generation long-acting antipsychotics in the treatment of patients with severe resistant schizophrenia. A mirror-image study
2025 · F. López-Muñoz, J. J. Fernández-Miranda, et al. · European Psychiatry
PDF
Effectiveness of oral versus long-acting injectable second-generation antipsychotics in suicide prevention among people with severe schizophrenia
2023 · J.J. Fernandez-Miranda, S. Díaz-Fernández · Neuroscience Applied
P.0394 Cognitive performance differences in patients with major depressive disorder treated with escitalopram, venlafaxine or vortioxetine. a 12-month follow-up
2021 · J.J. Fernandez-Miranda, D.F. Frías-Ortiz, et al. · European Neuropsychopharmacology
Works count: 31
Citation count: 209
H-index: 9
I10-index: 9
Year
Topic
Type